Onesource Specialty Pharma

Onesource Specialty Pharma Pretax Income

The Pretax Income (EBT) of Onesource Specialty Pharma (ONESOURCE.NS) as of Nov 3, 2026 is -919.61 M INR. In the previous year, Pretax Income (EBT) was -7.84 M INR — a change of 11,629.09% (lower).

Pretax Income

-919.61 MINR

YoY

11,629.09%

Last updated:

Pretax Income (EBT) of Onesource Specialty Pharma is 2026 -919.61 M INR. Pretax Income (EBT) of Onesource Specialty Pharma was 2025 -7.84 M INR. It decreases by 11,629.09% lower compared to the previous year.

The Onesource Specialty Pharma Pretax Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pretax Income
Date
Pretax Income
Jan 1, 2023
-4.16 B INR
Jan 1, 2024
-3.66 B INR
Jan 1, 2025
-7.84 M INR
Jan 1, 2026
-919.61 M INR
The Onesource Specialty Pharma Pretax Income history
YEARPretax IncomeYoY
-919.61 MINR+11,629.09%
-7.84 MINR-99.79%
-3.66 BINR-12.02%
-4.16 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Pretax Income (EBT) of Onesource Specialty Pharma is -919.61 M INR in 2026.

Pretax Income (EBT) of Onesource Specialty Pharma changed from -7.84 M INR to -919.61 M INR, representing a 11,629.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pretax Income (EBT) Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

Pretax income represents earnings before income taxes. It shows a company's profitability independent of tax strategies.

Pretax Income (EBT)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Pretax Income (EBT)'s Onesource Specialty Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Onesource Specialty Pharma

All Key Metrics — Onesource Specialty Pharma